Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus Rating of “Moderate Buy” from Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has been given a consensus rating of “Moderate Buy” by the twelve research firms that are covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $10.7778.

AVAH has been the subject of several research reports. Barclays lifted their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a report on Thursday, July 9th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Truist Financial lifted their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Finally, Royal Bank Of Canada raised shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price for the company in a research report on Wednesday, June 3rd.

Aveanna Healthcare Price Performance

AVAH opened at $9.69 on Friday. The stock has a market cap of $2.11 billion, a price-to-earnings ratio of 8.21, a PEG ratio of 0.96 and a beta of 1.89. Aveanna Healthcare has a 1 year low of $3.73 and a 1 year high of $10.32. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. The stock has a fifty day moving average price of $7.96 and a 200 day moving average price of $7.63.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The firm had revenue of $647.91 million for the quarter, compared to the consensus estimate of $613.22 million. The business’s revenue for the quarter was up 15.9% compared to the same quarter last year. Analysts forecast that Aveanna Healthcare will post 0.68 EPS for the current fiscal year.

Insider Buying and Selling at Aveanna Healthcare

In related news, major shareholder Paul R. Vigano sold 3,000,000 shares of the company’s stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total value of $24,030,000.00. Following the completion of the sale, the insider directly owned 190,130 shares in the company, valued at approximately $1,522,941.30. This represents a 94.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the stock in a transaction on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total transaction of $19,376,470.35. Following the transaction, the insider directly owned 10,112,123 shares in the company, valued at $80,998,105.23. The trade was a 19.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 31,305,664 shares of company stock worth $215,555,910 in the last 90 days. 5.30% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd lifted its holdings in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after purchasing an additional 2,400 shares during the last quarter. Quantbot Technologies LP acquired a new position in Aveanna Healthcare during the second quarter valued at approximately $43,000. Summit Securities Group LLC acquired a new position in Aveanna Healthcare during the first quarter valued at approximately $53,000. Oxford Asset Management LLP bought a new position in shares of Aveanna Healthcare in the second quarter valued at approximately $64,000. Finally, Bayesian Capital Management LP bought a new position in shares of Aveanna Healthcare in the second quarter valued at approximately $85,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.